Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis

European Respiratory Journal

Volumn 49, Issue 2, 2017, Pages

  Long, Xiaoping ^a,b   He, Xuan ^a   Ohshimo, Shinichiro ^c   Griese, Matthias ^d   Sarria, Rafael ^e   Guzman, Josune ^f   Costabel, Ulrich ^a   Bonella, Francesco ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b THE FIRST AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

^c HIROSHIMA UNIVERSITY   (Japan)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^f RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBON MONOXIDE; CHITINASE LIKE PROTEIN; PROTEIN; UNCLASSIFIED DRUG; YKL 40; CHI3L1 PROTEIN, HUMAN; CHITINASE 3 LIKE PROTEIN 1;

ADULT; ALLERGIC PNEUMONITIS; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CONTROLLED STUDY; DEATH; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SURVIVAL; BLOOD; CASE CONTROL STUDY; CHEMISTRY; DISEASE EXACERBATION; GERMANY; KAPLAN MEIER METHOD; MACROPHAGE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHIL; RECEIVER OPERATING CHARACTERISTIC; X-RAY COMPUTED TOMOGRAPHY;

ALVEOLITIS, EXTRINSIC ALLERGIC; BIOMARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CHITINASE-3-LIKE PROTEIN 1; DISEASE PROGRESSION; FEMALE; GERMANY; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG DISEASES, INTERSTITIAL; MACROPHAGES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHILS; RETROSPECTIVE STUDIES; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85028842093     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01924-2015     Document Type: Article

References (41)

1. Costabel U, Bonella F, Guzman J. Chronic hypersensitivity pneumonitis. Clin Chest Med 2012; 33: 151-163.
2. Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin Chest Med 2004; 25: 531-547.
3. Mohr LC. Hypersensitivity pneumonitis. Curr Opin Pulm Med 2004; 10: 401-411.
4. Jinta T, Miyazaki Y, Kishi M, et al. The pathogenesis of chronic hypersensitivity pneumonitis in common with idiopathic pulmonary fibrosis: expression of apoptotic markers. Am J Clin Pathol 2010; 134: 613-620.
5. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993; 268: 25803-25810.
6. Lee CG, Cruz CSD, Herzog E, et al. YKL-40, a chitinase-like protein at the intersection of inflammation and remodeling. Am J Respir Crit Care Med 2012; 185: 692-694.
7. Lee CG, Da Silva CA, Dela Cruz CS, et al. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol 2011; 73: 479-501.
8. Korthagen NM, van Moorsel CHM, Zanen P, et al. Evaluation of circulating YKL-40 levels in idiopathic interstitial pneumonias. Lung 2014; 192: 975-980.
9. Berres ML, Papen S, Pauels K, et al. A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection. J Hepatol 2009; 50: 370-376.
10. Bara I, Ozier A, Girodet PO, et al. Role of YKL-40 in bronchial smooth muscle remodeling in asthma. Am J Respir Crit Care Med 2012; 185: 715-722.
11. Erzin Y, Uzun H, Karatas A, et al. Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn's disease. J Gastroenterol Hepatol 2008; 23(8 Pt 2): e357-e362.
12. Kazakova M, Batalov A, Deneva T, et al. Relationship between sonographic parameters and YKL-40 levels in rheumatoid arthritis. Rheumatol Int 2013; 33: 341-346.
13. Furuhashi K, Suda T, Nakamura Y, et al. Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis. Respir Med 2010; 104: 1204-1210.
14. Johansen JS, Milman N, Hansen M, et al. Increased serum YKL-40 in patients with pulmonary sarcoidosis-a potential marker of disease activity? Respir Med 2005; 99: 396-402.
15. Long X, Costabel U, He X, et al. Serum YKL-40 as a candidate biomarker for hypersensitivity pneumonitis. Pneumologie 2015; 69: S5.
16. Lacasse Y, Selman M, Costabel U, et al. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003; 168: 952-958.
17. Raghu G, Collard HR, Egan JJ, et al. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med 2011; 183: 788-824.
18. ATS/ERS. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
19. Travis WD, Costabel U, Hansell DM, et al. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2013; 188: 733-748.
20. Bonella F, Ohshimo S, Miaotian C, et al. Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis. Orphanet J Rare Dis 2013; 8: 53.
21. Schmidt SL, Tayob N, Han MK, et al. Predicting pulmonary fibrosis disease course from past trends in pulmonary function. Chest 2014; 145: 579-585.
22. Klech H, Pohl W. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group. Eur Respir J 1989; 2: 561-585.
23. Korthagen NM, van Moorsel CHM, Barlo NP, et al. Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis. Respir Med 2011; 105: 106-113.
24. Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 1-100.
25. Liu CY, Li Q, Zhou XD, et al. The chitinase-like protein YKL-40 increases mucin5AC production in human bronchial epithelial cells. Exp Cell Res 2013; 319: 2866-2873.
26. Riabov V, Gudima A, Wang N, et al. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Physiology 2014; 5: 75.
27. Tang H, Fang Z, Sun Y, et al. YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E. Eur Respir J 2010; 35: 757-760.
28. Kruit A, Grutters JC, Ruven HJT, et al. A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respir Med 2007; 101: 1563-1571.
29. Drent M, Cobben NA, Henderson RF, et al. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J 1996; 9: 1736-1742.
30. Mooney JJ, Elicker BM, Urbania TH, et al. Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis. Chest 2013; 144: 586-592.
31. Walsh SLF, Sverzellati N, Devaraj A, et al. Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants. Eur Radiol 2012; 22: 1672-1679.
32. Miyazaki Y, Tateishi T, Akashi T, et al. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest 2008; 134: 1265-1270.
33. Ishikawa N, Hattori N, Yokoyama A, et al. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases. Respir Investig 2012; 50: 3-13.
34. Ohnishi H, Miyamoto S, Kawase S, et al. Seasonal variation of serum KL-6 concentrations is greater in patients with hypersensitivity pneumonitis. BMC Pulm Med 2014; 14: 129.
35. Miyazaki Y, Unoura K, Tateishi T, et al. Higher serum CCL17 may be a promising predictor of acute exacerbations in chronic hypersensitivity pneumonitis. Respir Res 2013; 14: 57.
36. Guerra S, Halonen M, Sherrill DL, et al. The relation of circulating YKL-40 to levels and decline of lung function in adult life. Respir Med 2013; 107: 1923-1930.
37. Matsuura H, Hartl D, Kang MJ, et al. Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema. Am J Respir Cell Mol Biol 2011; 44: 777-786.
38. Sakazaki Y, Hoshino T, Takei S, et al. Overexpression of chitinase 3-like 1/YKL-40 in lung-specific IL-18-transgenic mice, smokers and COPD. PLoS One 2011; 6: e24177.
39. Li XY, Donaldson K, Rahman I, et al. An investigation of the role of glutathione in increased epithelial permeability induced by cigarette smoke in vivo and in vitro. Am J Respir Crit Care Med 1994; 149: 1518-1525.
40. Johansen JS, Stoltenberg M, Hansen M, et al. Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity. Rheumatology (Oxford) 1999; 38: 618-626.
41. Kzhyshkowska J, Mamidi S, Gratchev A, et al. Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 2006; 107: 3221-3228.